ZA902033B - New 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

New 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA902033B
ZA902033B ZA902033A ZA902033A ZA902033B ZA 902033 B ZA902033 B ZA 902033B ZA 902033 A ZA902033 A ZA 902033A ZA 902033 A ZA902033 A ZA 902033A ZA 902033 B ZA902033 B ZA 902033B
Authority
ZA
South Africa
Prior art keywords
phenyl
alkyl
phenylalkyl
pyridyl
hydroxyalkyl
Prior art date
Application number
ZA902033A
Other languages
English (en)
Inventor
Claude James
James Claude
Daniel Lave
Lave Daniel
Francoise Soler
Soler Francoise
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of ZA902033B publication Critical patent/ZA902033B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA902033A 1989-03-17 1990-03-16 New 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide derivatives,their preparation and pharmaceutical compositions containing them ZA902033B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA902033B true ZA902033B (en) 1990-12-28

Family

ID=9379793

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902033A ZA902033B (en) 1989-03-17 1990-03-16 New 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide derivatives,their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US5086051A (fi)
EP (1) EP0388309B1 (fi)
JP (1) JPH02289586A (fi)
KR (1) KR900014408A (fi)
AT (1) ATE102210T1 (fi)
BG (1) BG51159A3 (fi)
CA (1) CA2012343A1 (fi)
CS (2) CS276785B6 (fi)
DD (1) DD297822A5 (fi)
DE (1) DE69006872T2 (fi)
DK (1) DK0388309T3 (fi)
ES (1) ES2062432T3 (fi)
FI (1) FI92069C (fi)
FR (1) FR2644456B1 (fi)
IE (1) IE63313B1 (fi)
IL (1) IL93760A (fi)
MA (1) MA21771A1 (fi)
MX (1) MX26542A (fi)
NO (1) NO172392C (fi)
NZ (1) NZ232960A (fi)
PL (1) PL284321A1 (fi)
PT (1) PT93485B (fi)
TN (1) TNSN90030A1 (fi)
ZA (1) ZA902033B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (fi) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
DK0650485T3 (da) 1992-07-13 2001-01-22 Millennium Pharm Inc 2,5-Diaryltetrahydrothiophener, -furaner og analoger til behandling af inflammatoriske forstyrrelser og immunforstyrrelser
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
TW266206B (fi) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
DE69701298T2 (de) * 1996-04-15 2000-10-05 Takeda Chemical Industries Ltd Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
JP5169216B2 (ja) * 2005-08-19 2013-03-27 独立行政法人産業技術総合研究所 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2012343A1 (fr) 1990-09-17
IL93760A0 (en) 1990-12-23
FI92069C (fi) 1994-09-26
DD297822A5 (de) 1992-01-23
IL93760A (en) 1994-08-26
EP0388309A3 (fr) 1991-07-24
CS276785B6 (en) 1992-08-12
US5086051A (en) 1992-02-04
NO901237L (no) 1990-09-18
FR2644456A1 (fr) 1990-09-21
NZ232960A (en) 1991-02-26
TNSN90030A1 (fr) 1991-03-05
ATE102210T1 (de) 1994-03-15
DK0388309T3 (da) 1994-04-11
MA21771A1 (fr) 1990-10-01
FI92069B (fi) 1994-06-15
DE69006872D1 (de) 1994-04-07
EP0388309B1 (fr) 1994-03-02
EP0388309A2 (fr) 1990-09-19
ES2062432T3 (es) 1994-12-16
CS125290A3 (en) 1992-03-18
NO172392C (no) 1993-07-14
FI901325A0 (fi) 1990-03-16
NO172392B (no) 1993-04-05
NO901237D0 (no) 1990-03-16
IE63313B1 (en) 1995-04-05
MX26542A (es) 1993-09-01
DE69006872T2 (de) 1994-06-30
IE900984L (en) 1990-09-17
PT93485B (pt) 1996-02-29
JPH02289586A (ja) 1990-11-29
BG51159A3 (en) 1993-02-15
PL284321A1 (en) 1991-07-29
CS438990A3 (en) 1992-03-18
PT93485A (pt) 1990-11-07
FR2644456B1 (fr) 1991-07-05
KR900014408A (ko) 1990-10-23

Similar Documents

Publication Publication Date Title
IL93760A0 (en) 1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
PH23739A (en) Piperidine derivative and pharmaceutical composition
IL55930A (en) Phenylalkoxydihydroxyoctahydrophenanthrenes,pharmaceutical compositions containing them and intermediates for their preparation
NZ234110A (en) Dibenzoazepine, -oxepine and -cycloheptane substituted alkylidene amines; pharmaceutical compositions containing such compounds or various other aryl substituted amines
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
YU130584A (en) Process for making 1,4-dihydropyridine
IL76175A (en) N-substituted tricyclic oxindole carboxamides and pharmaceutical compositions containing them
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
ES8601211A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
ZA857457B (en) Furo(3,2-c)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL61911A (en) 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
ES8406456A1 (es) Procedimiento de preparacion de derivados de piperacina
IL90172A (en) 2,3-dihydro-5-(substituted phenyl)-imidazo(1,2-a)furo and thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them
NZ222973A (en) Substituted piperidine and azepine derivatives and pharmaceutical compositions